Acceptance of COVID-19 vaccine in Pakistan: A nationwide cross-sectional study by Qamar, Mohammad Aadil et al.
eCommons@AKU 
Department of Paediatrics and Child Health Division of Woman and Child Health 
7-24-2021 
Acceptance of COVID-19 vaccine in Pakistan: A nationwide cross-
sectional study 
Mohammad Aadil Qamar 
Omar Irfan 
Rubaid A. Dhillon 
Areesh Bhatti 
Mir Ibrahim Sajid 
See next page for additional authors 
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_paediatr 
 Part of the Influenza Virus Vaccines Commons, Pulmonology Commons, and the Virus Diseases 
Commons 
Authors 
Mohammad Aadil Qamar, Omar Irfan, Rubaid A. Dhillon, Areesh Bhatti, Mir Ibrahim Sajid, Safia Awan, 
Wajiha Rizwan, Ali Bin Sarwar Zubairi, Zouina Sarfraz, and Javaid Ahmed Khan 
Review began  07/07/2021 
Review ended  07/10/2021 
Published 07/24/2021
© Copyright 2021
Qamar et al. This is an open access article
distributed under the terms of the
Creative Commons Attribution License
CC-BY 4.0., which permits unrestricted
use, distribution, and reproduction in any
medium, provided the original author and
source are credited.
Acceptance of COVID-19 Vaccine in Pakistan: A
Nationwide Cross-Sectional Study
Mohammad Aadil Qamar  , Omar Irfan  , Rubaid A. Dhillon  , Areesh Bhatti  , Mir Ibrahim Sajid  , Safia
Awan  , Wajiha Rizwan  , Ali Bin Sarwar Zubairi  , Zouina Sarfraz  , Javaid Ahmed Khan 
1. Internal Medicine, Ziauddin University, Karachi, PAK 2. Pediatrics, Centre for Global Child Health, Hospital for Sick
Children, Toronto, CAN 3. Internal Medicine, Riphah International University, Rawalpindi, PAK 4. Pediatrics, The Aga
Khan University, Karachi, PAK 5. Internal Medicine, The Aga Khan University, Karachi, PAK 6. Pediatrics, The Children
Hospital and Institute of Child Health, Lahore, PAK 7. Pulmonology, The Aga Khan University, Karachi, PAK 8. Internal
Medicine, Fatima Jinnah Medical University, Lahore, PAK
Corresponding author: Zouina Sarfraz , zouinasarfraz@gmail.com
Abstract
Introduction
The coronavirus disease 2019 (COVID-19) vaccine is available across various countries worldwide, with
public-private partnerships ensuring all individuals are vaccinated through a phased approach. Irrespective
of the geographical spread, several myths pertaining to the COVID-19 vaccine have stemmed, ultimately
limiting the national administration of vaccines and rollouts. This study assessed the acceptance of the
COVID-19 vaccine among the general public in Pakistan.
Methods
A pre-validated questionnaire was administered from January 2021 to February 2021 to assess the public
attitude and acceptance of the COVID-19 vaccine. Logistic regression analyses were run to identify factors
associated with the acceptance among the population.
Results
A total of 936 responses were elicited, where 15% perceived their risk of being infected at 20-30% with an
overall 70% agreeing to be vaccinated if recommended. Multivariate analysis identified higher acceptance in
the male gender, healthcare workers, and students. Of all, 66% respondents chose healthcare workers and
public officials, whereas 15.6% chose scientific literature, and 12.9% chose social media as the most reliable
source of COVID-19 information.
Conclusion
Given the relatively greater trust in healthcare providers for information regarding COVID-19, healthcare
workers ought to be on the frontline for vaccine campaigns and public outreach efforts, with governmental
efforts in addition to the promotion of scientific materials for population-level understanding.
Categories: Infectious Disease, Public Health
Keywords: covid-19, vaccination, acceptability, pakistan, public health
Introduction
The coronavirus disease 2019 (COVID-19) pandemic began as a cluster of respiratory tract infections of
unknown origin in Wuhan, China. As a mutated variant of the coronavirus family and given extensive
contact with the center of the outbreak, COVID-19 dispersed worldwide. As of June 29, 2021, 181.5 million
confirmed cases have been reported worldwide to the World Health Organization (WHO), with 3.9 million
casualties [1,2]. A total of 0.95 million confirmed COVID-19 cases have been reported from Pakistan, as of
June 29, 2021 [1,2]. Notably, the vaccine doses administered as of June 29, 2021, are 2.9 billion, as reported
to the WHO [1].
Pakistan comprises a diverse population comprising a multitude of ethnic, religious, and socio-economic
groups. Among them lies a fraction of the population which has previously opposed the use of polio
vaccinations, resulting in Pakistan being one of the three countries that still reports polio cases [3]. Among
the many challenges that were faced in the acceptance of polio vaccination programs, one was the alleged
myth concerning the biological effects of the vaccine [4]. The myth was propagated primarily by certain
religious clerics, which was also raised in the case of COVID-19 vaccines, ranging from the vaccine’s ability
to alter DNA to the insertion of microchips in controlling human behaviors [4]. As a low- and middle-income
country (LMIC) with poor health infrastructure and a limited budget to provide advanced point-of-care
treatment, Pakistan would have had to enforce the mantra of “prevention is better than cure,” to counter the
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myths [5].
With five vaccines (AstraZeneca, Sinopharm, CanSino, Sputnik V, and Gamaleya) approved for use in
Pakistan as of June 29, 2021, along with the phased rollout approach of mass vaccination, this study aimed
to assess the acceptance of the COVID-19 vaccine among the general public. This study also aimed to inform
medical communities about the causes of gaps in vaccine administration in LMIC, with relevant public
health findings to ensure uniform vaccine rollouts.
Materials And Methods
A large-scale, cross-sectional study was conducted to assess the acceptability of the COVID-19 vaccine
among the Pakistani population from January 2021 to February 2021. Ethical approval was obtained from the
Ethical Review Committee of Islamic International Medical College, Rawalpindi (Riphah/IIMC/ ERC/146). An
online questionnaire prepared on Google Forms both in Urdu and English was disseminated to be filled by
consenting individuals aged 18 years or more. The study investigators in consultation with subject experts
administered a previously validated questionnaire for the study [6,7]. The questionnaire was run through
pilot testing consisting of 40 participants comprising various field experts and layman individuals to ensure
the clarity and relevance of the contents being assessed. The responses obtained during the pilot testing
were not included during the final analysis of data.
The survey consisted of two main sections; first, respondent demographics (socio-economic status and
relevant comorbidities), and second, vaccine attitude, to assess vaccine acceptance under different
circumstances. The first section incorporated demographic questions with select options addressing age,
gender, province, education, employment, income, marital status, occupation, and comorbidity. The second
section employed the use of polar questions and the Likert scale on four occasions to assess the level of trust
the people placed on the government, reliability of media as a source of accurate pandemic information,
compliance to get vaccinated, and to ascertain the severe effects of COVID-19 if the disease was contracted.
The sample size was calculated using OpenEpi (Version 3.01; Open Source Epidemiologic Statistics for Public
Health), which was estimated to be 683 participants (95% confidence interval {CI}, bound on the error of 3%,
and 50% acceptability). The final enrollment included 1000 participants to account for the accretion rate,
and to compensate for any missing data in the final dataset. To analyze the data, SPSS Version 25 (Chicago,
IL: IBM® SPSS® Statistics) was utilized. Quantitative variables were represented as mean and standard
deviation (SD), whereas frequencies were used for qualitative variables. The comparison of acceptance of
vaccines among different groups within the socio-demographic was assessed using the chi-square test and/or
Fisher's exact test, where appropriate. Univariate and multivariate analyses were performed to compare the
acceptance of the vaccine with the variables of interest. The test result was considered statistically
significant if the p-value was 0.05 or less.
Results
Of the 1000 forms that were distributed, a total of 936 participants completed the online questionnaire,
yielding a response rate of 93.6%. A significant majority of the population were females (n=558, 59.6%), aged
between 20 years and 29 years (n=411, 43.9%), not-married (n=708, 75.6%) and were residents of the
province, Punjab (n=485, 51.8%). A detailed analysis of the patient demographics can be visualized in Table
1.
Variable Total: n (%) Vaccine accepted N=656: n (%) Vaccine refused N=280: n (%) p-value
Age (years)
<0.001
18-19 359 (38.4) 226 (34.5) 133 (47.5)
20-29 411 (43.9) 319 (48.6) 92 (32.9)
30-39 98 (10.5) 69 (10.5) 29 (10.4)
40-49 25 (2.7) 19 (2.9) 6 (2.1)
50-59 28 (3) 16 (2.4) 12 (4.3)
>60 15 (1.6) 7 (1.1) 8 (2.9)
Gender
0.009Male 378 (40.4) 283 (43.1) 95 (33.9)
Female 558 (59.6) 373 (56.9) 185 (66.1)
Province
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Sindh 341 (36.4) 261 (39.8) 80 (28.6)
0.01
Punjab 485 (51.8) 318 (48.5) 167 (59.6)
Balochistan 34 (3.6) 22 (3.4) 12 (4.3)
Khyber Pakhtunkhwa 64 (6.8) 47 (7.2) 17 (6.1)
Gilgit-Baltistan 12 (1.3) 8 (1.2) 4 (1.4)
Education
0.003
No formal education 21 (2.2) 10 (1.5) 11 (3.9)
Primary school 3 (0.3) 2 (0.3) 1 (0.4)
Secondary school 105 (11.2) 80 (12.2) 25 (8.9)
Bachelor/university 608 (65) 441 (67.2) 167 (59.6)
Master/PhD 185 (19.8) 117 (17.8) 68 (24.3)
Diploma 14 (1.5) 6 (0.9) 8 (2.9)
Occupation
<0.001
Unemployed 149 (15.9) 105 (16) 44 (15.7)
Retired 6 (0.6) 6 (0.9) 0 (0)
Private sector 187 (20) 147 (22.4) 40 (14.3)
Government employee 44 (4.7) 38 (5.8) 6 (2.1)
Business 39 (4.2) 25 (3.8) 14 (5)
Student 505 (54) 334 (50.9) 171 (61.1)
Unskilled worker 6 (0.6) 1 (0.2) 5 (1.8)
Income (in Pakistani rupees)
<0.001
<10,000 52 (5.6) 38 (5.8) 14 (5)
10,000-49,999 95 (10.1) 71 (10.8) 24 (8.6)
50,000-100,000 94 (10) 75 (11.4) 19 (6.8)
>100,000 122 (13) 100 (15.2) 22 (7.9)
Not applicable 573 (61.2) 372 (56.7) 201 (71.8)
Marital status
0.005
Married 209 (22.3) 145 (22.1) 64 (22.9)
Single 708 (75.6) 504 (76.8) 204 (72.9)
Divorced 19 (2) 7 (1.1) 12 (4.3)
Occupation
0.003
Healthcare workers 133 (14.2) 107 (16.3) 26 (9.3)
Medical students 298 (31.8) 216 (32.9) 82 (29.3)
None of the above 505 (54) 333 (50.8) 172 (61.4)
Presence of COVID-19 infection in family or friends 427 (45.6) 333 (50.8) 94 (33.6) <0.001
Comorbidity
0.69Yes 130 (13.9) 93 (14.2) 37 (13.2)
No 806 (86.1) 563 (85.8) 243 (86.8)
TABLE 1: Characteristics of the study population (N=936)
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Around half of the study population (n=427, 45.6%) reported a relative or a friend who had contracted
COVID-19. The participants reported their perceptions toward COVID-19 and response towards the vaccine
as a percentage (i.e. 0-10%, 10-20%), shown in Table 2. One-third of the population believed that they had
less than a 10% risk of contracting COVID-19, and only 20.2% of the population believed that they had more
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Agree 189
(20.2)
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TABLE 2: Responses on vaccine acceptance (N=936)
COVID-19: coronavirus disease 2019
Overall, 70.1% of the population reported willingness to get the COVID-19 vaccine if available and
recommended by healthcare workers. When asked if they would get the vaccine with 95% effectiveness for a
cost, 77.1% of our respondents responded in the affirmative, compared to only 41.2% who were willing to get
vaccinated with a 50% effective vaccine for a cost. In contrast, 85.4% stated they would get vaccinated with a
95% effective vaccine if freely available. Whereas 55.7% stated that they would get vaccinated with a 50%
effective vaccine if freely available. Table 3 presents a univariate analysis of the findings.
Variable Odds ratio 95% confidence intervals p-value
Age (years)
18-19 [reference]
20-29 2.04 1.48-2.79 <0.001
30-39 1.40 0.86-2.27 0.17
40-49 1.86 0.72-4.78 0.19
50-59 0.78 0.36-1.70 0.54
>60 0.51 0.18-1.45 0.21
Gender
Female [reference]
Male 1.47 1.10-1.97 0.009
Province
Gilgit-Baltistan [reference]
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Sindh 1.63 0.47-5.55 0.43
Punjab 0.95 0.28-3.20 0.93
Balochistan 0.91 0.22-3.68 0.90
Khyber Pakhtunkhwa 1.38 0.36-5.18 0.63
Education
No formal education [reference]
Primary school 2.2 0.17-28.13 0.54
Secondary school 3.52 1.33-9.25 0.01
Bachelor/university 2.9 1.21-6.96 0.01
Master/PhD 1.89 0.76-4.68 0.16
Diploma 0.82 0.21-3.21 0.78
Occupation
Unemployed/retired [reference]
Private sector 1.30 0.8-2.11 0.28
Government employee 2.51 0.99-6.35 0.052
Business 0.7 0.33-1.48 0.36
Student 0.77 0.52-1.14 0.20
Income (in Pakistani rupees)
<10,000 [reference]
10,000-49,999 1.09 0.5-2.34 0.82
50,000-100,000 1.45 0.65-3.21 0.35
>100,000 1.67 0.77-3.60 0.18
Marital status
Married [reference]
Single 1.09 0.77-1.52 0.61
Divorced 0.25 0.09-0.68 0.007
Occupation
None of the below [reference]
Healthcare worker 2.12 1.33-3.38 0.002
Medical students 1.36 0.99-1.86 0.054
Presence of COVID-19 infection in family or friends
No [reference]
Yes 2.04 1.52-2.73  
Comorbidity
No [reference]
Yes 1.08 0.72-1.63 0.69
Perceived risk of being infected with COVID-19
0-30% [reference]
40-60% 1.68 1.22-2.29 0.001
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>60% 2.42 1.41-4.16 0.001
Confidence in the reliability of media sources regarding COVID-19
No [reference]
Yes 2.26 1.66-3.07 <0.001
Influenza/flu vaccine/flu shots administered every year
No [reference]
Yes 1.47 1.05-2.07 0.02
Trust in the national government to control the pandemic
No [reference]
Yes 1.74 1.30-2.33 <0.001
COVID-19 can be debilitating and dangerous to health
No [reference]
Yes 2.67 2-3.58 <0.001
Source considered the most reliable regarding COVID-19 information
Healthcare workers [reference]
Healthcare officials 1.05 0.64-1.71 0.84
Social media 0.53 0.35-0.81 0.003
Scientific literature/internet 1.53 0.97-2.4 0.64
Other sources 0.22 0.12-0.41 <0.001
TABLE 3: Univariate analysis of the determinants of COVID-19 vaccine acceptance
COVID-19: coronavirus disease 2019
Over 27.3% of the respondents did not perceive the media to be a reliable source of information regarding
COVID-19, whereas 38.9% perceived it to be reliable, and the remaining (33.8%) were neutral to media
outlets. When asked to choose what they perceived to be the most reliable source of information regarding
COVID-19, 66% of the respondents chose healthcare workers and officials, 15.6% chose scientific literature
and the internet, and 12.9% chose social media.
The multivariate analysis identified that first male gender, second healthcare workers and medical students,
third respondents whose family or friends had contracted COVID-19, and fourth individuals who trusted
media as a reliable source for COVID-19 were more receptive to the vaccine. Participants’ belief that
COVID-19 can be debilitating and dangerous to their health was also significantly linked to greater
acceptance of the vaccine. The results of the multivariate analysis are depicted in Table 4.
2021 Qamar et al. Cureus 13(7): e16603. DOI 10.7759/cureus.16603 7 of 10
Variable Odds ratio (95% confidence intervals) p-value
Gender
Female [reference]
Male 1.65 (1.2-2.26) 0.002
Occupation
None of the below [reference]
Healthcare worker 2.1 (1.25-3.51) 0.005
Medical students 1.64 (1.16-2.31) 0.004
Presence of COVID-19 infection in family or friends
No [reference]
Yes 2.11 (1.53-2.91) <0.001
Confidence in the reliability of media sources regarding COVID-19
No [reference]
Yes 2.11 (1.48-3.01) <0.001
Trust in the national government to control the pandemic
No [reference]
Yes 1.49 (1.06-2.10) 0.02
COVID-19 can be debilitating and dangerous to health
No [reference]
Yes 2.28 (1.68-3.11) <0.001
TABLE 4: Multivariate analysis of the determinants of COVID-19 vaccine acceptance
COVID-19: coronavirus disease 2019
Discussion
The COVID-19 vaccine is being rolled out using a phased approach to immunize individuals in Pakistan to
achieve herd immunization. Our study shows that males, healthcare workers, and medical students are more
likely to accept the vaccine, whereas the chances of immunizing the masses are higher if the vaccine is given
free of cost. Irrespective of vaccination costs, a statistically higher proportion of individuals were keen on
getting the vaccine with a 95% efficacy as opposed to those with 50% efficacy rates.
Previously conducted surveys found that adequate knowledge among the general public is a critical
determinant of infection prevention and control. In contrast to the more severe second wave of COVID-19
infection in Pakistan, a large cross-sectional survey of 1200 Pakistani residents during the first wave found
that 93.3% of the surveyed population had adequate knowledge of COVID-19 precautionary measures [8].
Our study indicates that 70.1% of the population were willing to get the vaccine if it became available and
was recommended by a credible source. The finding is aligned with India, another LMIC that has similar
literacy rates, and socio-economic conditions to Pakistan. The vaccine acceptance measured among the
general public in India was found to be 74% [9]. Among countries with higher incomes and literacy, scientific
literature notes lower acceptance rates for the vaccine; with 64.7% in Saudi Arabia [10] and 67% in the
United States [7].
We evaluated the importance of factors such as the cost of the vaccine, reported effectiveness, and the
duration of protection in determining acceptability in the population. The data showed that if a paid vaccine
with 95% and 50% effectiveness became available, only 77.1% and 41.2% of the participants would,
respectively, get the vaccine. However, if the two vaccines were made available free of cost, the acceptance
would increase to 85.4% and 55.7% concerning vaccines with 95% and 50% effectiveness, respectively. This
was in line with the results published by Harapan and colleagues from Indonesia, where 93% and 67% of the
participants were willing to receive the vaccine if provided free of cost with a 95% and 50% effectiveness,
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respectively [6]. Prominent works such as Jeffery and colleagues showed that the differences in acceptance
rates ranged from 90% in China to less than 55% in Russia [11].
The myth about the COVID-19 infection and vaccination persists in Pakistan, with religious undertones in
the country [12]. Sentiments have been expressed such as the virus being an attack on Islamic nations and
the vaccine containing micro-chips allowing governments to gain control of vaccinated individuals through
the introduction of fifth-generation technology [12]. Ultimately, this has led to lower community trust, as
documented with a 44.5% trust in the government shown in our study. These are worrisome trends since
several studies report that populations with higher trust in the national healthcare systems are associated
with higher vaccine acceptance and other health services [13,14]. Our data also revealed that 66% of the
population considered healthcare professionals and officials as a reliable source of information for COVID-
19. Furthermore, a large proportion of vaccine acceptance is seen among healthcare workers and student
groups as compared to non-healthcare workers. A systematic analysis by Vasilevska and colleagues found
that healthcare workers are at a greater risk of contracting the infection and the central means of protecting
themselves, and their families are through vaccination [15]. Healthcare workers may be further engaged by
utilizing social media as a means to promote the importance of COVID-19 vaccine acceptance among the
community.
Amyn and colleagues evaluated the determinants of COVID-19 vaccine acceptance among the general
population in the United States [7]. The general public showed a lower interest in being vaccinated as
compared to our study participants; 67% in the United States versus 71% in our study [7]. The study showed
that 72% males, 78% adults aged 55 years or above, 81% Asians, and 75% college and/or graduate degree
holders were more willing to accept the vaccine as compared to other groups [7]. Even though we had a lower
representation of the older age groups in Pakistan, of the 43 older aged individuals who completed the
survey, 23 (53.4%) of the individuals were willing to get the COVID-19 vaccine. Similarly, 608 (65%)
university students with a bachelor's degree and 199 (21.3%) individuals with a higher-level degree were
more willing to partake in the immunization program as opposed to the 21 (2.2%) lesser-educated
individuals.
Gul Deniz and colleagues conducted an online survey to ascertain the hesitancy of vaccine administration in
the United Kingdom and Turkey [16]. In both countries, around 3% of the individuals presented with no
intention of obtaining the COVID-19 vaccine, where 31% of participants in Turkey and 14% in the United
Kingdom were unsure about the vaccine [16]. Overall, 54% of the participants in Turkey and 63% in the
United Kingdom believed that the outbreak of the novel coronavirus was natural, with no attributable
conspiracy theories, finally leading to increased willingness of obtaining the COVID-19 vaccine [16].
Limitations
The present study had certain limitations. Firstly, due to the state-wide lockdowns, the available method to
distribute the survey was a multitude of online platforms, employing the non-probability convenient
sampling strategy which may not portray an accurate image of the participants in our population. Secondly,
groups with limited access to online platforms could not fill our survey, leading to an underrepresentation of
individuals from lower socioeconomic classes. Thirdly, around 80% of the participants were aged 30 years or
less, and had a bachelor’s degree, leading to an overestimation of vaccine acceptance among the Pakistani
population. Notably, the survey was distributed using social media platforms with 76 million Internet users
in Pakistan; of which, 63% of users were in the age group of 20 to 25 years, according to the Pakistan
Telecommunication Authority [17]. Lastly, this study did not measure the knowledge of COVID-19 among
the participants, therefore, we were unable to derive any associations of acceptance with previous
knowledge of the disease. However, our study is the first to assess the large-scale acceptance of COVID-19
in Pakistan that strategically evaluates vaccine uptake behaviors tied in with demographic and geographic
factors across the country. During the data collection of this survey, several reports were available reporting
the efficiencies of vaccines, therefore our findings are based on real-time associations of vaccine trials and
administration to acceptance by the Pakistani population.
Conclusions
This is the first study from Pakistan that depicts the population-level acceptance of the COVID-19 vaccine
and the influencing factors. These contributors vary significantly with demographics and geographical
disparities. Based on our study findings, the most important determinants of vaccine acceptance were, first,
dissemination of credible information, second, source of evidence like healthcare workers or government
officials, third, social media influencer channels, and fourth media outlets. The central determinants of
vaccine acceptance in Pakistan may be optimized for public health vaccination at the governmental and
health sector level to increase compliance of vaccine administration across low- and middle-income
countries. The social determinants of vaccine acceptance, demographical and geographical differences, may
be utilized to recommend targeted public health strategies and uniform vaccine rollouts for the ongoing
COVID-19 pandemic and global outbreaks in the future.
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